Loading...
When FDA class D or X medications are prescribed to women of reproductive age, concomitant contraceptive counseling is essential; however, this practice often receives inadequate attention. Researchers at a South Carolina family medicine clinic in a community-based residency training program conducted a prospective study to evaluate efficacy of an educational intervention to promote contraceptive counseling by clinicians when teratogenic medications are prescribed. Electronic medical records of office visits by women (age range, 15–44) who were prescribed class D or X drugs (e.g., paroxetine, warfarin, statins) were evaluated before (265 prescriptive encounters) and after (233 encounters) educational intervention to determine whether contra…